Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients

Blood. 2016 Oct 20;128(16):2093-2095. doi: 10.1182/blood-2016-07-728261. Epub 2016 Aug 22.

¹ Hematology Unit, Department of Onco-hematology, Azienda Ospedaliera of Cosenza, Cosenza, Italy.
² Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
³ Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland.
⁴ Department of Hematology, Catholic University Hospital "A. Gemelli," Rome, Italy.
⁵ Divisione di Ematologia, Università La Sapienza, Roma, Italy.
⁶ Department of Oncology and Haematology, Pugliese-Ciaccio Hospital, Catanzaro, Italy.
⁷ Molecular Pathology Unit, Istituto di ricovero e cura a carattere scientifico (IRCCS), San Martino-IST, Genoa, Italy.
⁸ Consiglio Nazionale delle Ricerche, Istituto di Biomedicina ed Immunologia Molecolare, Reggio Calabria, Italy.
⁹ Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN.
¹⁰ Biotechnology Research Unit, Azienda Sanitaria Provinciale di Cosenza, Aprigliano, Italy.
¹¹ Department of Oncology and Hemato-oncology, University of Milano and Hematology Centro Trapianto di Midollo Osseo, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
¹² Direzione Scientifica IRCCS, San Martino-IST, Genoa, Italy; and.
¹³ Division of Haematology, Department of Translational Medicine, Università degli Studi del Piemonte Orientale "Amedeo Avogadro," Novara, Italy.

No abstract available

Publication types